Genome-wide association study and targeted metabolomics identifies sex-specific association of CPS1 with coronary artery disease

[1]  Sebastian M. Armasu,et al.  A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2015, Nature Genetics.

[2]  Richard G. Lee,et al.  The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance. , 2015, Cell Reports.

[3]  Brian J. Bennett,et al.  Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis[S] , 2015, Journal of Lipid Research.

[4]  Harish Dharuri,et al.  Insight in Genome-Wide Association of Metabolite Quantitative Traits by Exome Sequence Analyses , 2015, PLoS genetics.

[5]  S. Hazen,et al.  Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry. , 2014, Analytical biochemistry.

[6]  Brian J. Bennett,et al.  Comparative Genome-Wide Association Studies in Mice and Humans for Trimethylamine N-Oxide, a Proatherogenic Metabolite of Choline and L-Carnitine , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[7]  John P. Overington,et al.  An atlas of genetic influences on human blood metabolites , 2014, Nature Genetics.

[8]  S. Hazen,et al.  Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. , 2014, European heart journal.

[9]  Eric Boerwinkle,et al.  Genetic Determinants Influencing Human Serum Metabolome among African Americans , 2014, PLoS genetics.

[10]  Stephen R. Williams,et al.  Genome-Wide Meta-Analysis of Homocysteine and Methionine Metabolism Identifies Five One Carbon Metabolism Loci and a Novel Association of ALDH1L1 with Ischemic Stroke , 2014, PLoS genetics.

[11]  A. Lusis,et al.  Systems genetics approaches to understand complex traits , 2013, Nature Reviews Genetics.

[12]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[13]  C. Gerloff,et al.  Homoarginine Levels Are Regulated by L-Arginine: Glycine Amidinotransferase and Affect Stroke Outcome Results From Human and Murine Studies , 2013, Circulation.

[14]  T. Lehtimäki,et al.  Genome-Wide Association Study Identifies 3 Genomic Loci Significantly Associated With Serum Levels of Homoarginine: The AtheroRemo Consortium , 2013, Circulation. Cardiovascular genetics.

[15]  Andrew D. Johnson,et al.  Multiethnic Meta-Analysis of Genome-Wide Association Studies in >100 000 Subjects Identifies 23 Fibrinogen-Associated Loci but No Strong Evidence of a Causal Association Between Circulating Fibrinogen and Cardiovascular Disease , 2013, Circulation.

[16]  Andrew D. Johnson,et al.  Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease. , 2013, The American journal of clinical nutrition.

[17]  M. Fornage,et al.  Genome-wide and Gene-centric Analyses of Circulating Myeloperoxidase Levels in the Charge and Care Consortia Department of Health Services and Research Unit of Molecular Epidemiology And , 2022 .

[18]  Ming-Huei Chen,et al.  A genome-wide association study of the human metabolome in a community-based cohort. , 2013, Cell metabolism.

[19]  R. Gerszten,et al.  Toward new biomarkers of cardiometabolic diseases. , 2013, Cell metabolism.

[20]  Jussi Paananen,et al.  Genetic Variants Associated With Glycine Metabolism and Their Role in Insulin Sensitivity and Type 2 Diabetes , 2013, Diabetes.

[21]  Guoyao Wu,et al.  Glycine metabolism in animals and humans: implications for nutrition and health , 2013, Amino Acids.

[22]  S. Hazen,et al.  Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. , 2013, The New England journal of medicine.

[23]  F. Bushman,et al.  Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis , 2013, Nature Medicine.

[24]  Brian J. Bennett,et al.  Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. , 2013, Cell metabolism.

[25]  J. Erdmann,et al.  Clinical and Genetic Association of Serum Paraoxonase and Arylesterase Activities With Cardiovascular Risk , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[26]  H. Morizono,et al.  A novel biochemically salvageable animal model of hyperammonemia devoid of N-acetylglutamate synthase. , 2012, Molecular genetics and metabolism.

[27]  Ruth McPherson,et al.  Clinical and Genetic Association of Serum Ceruloplasmin With Cardiovascular Risk , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[28]  H. Wakiguchi,et al.  Cysteine, histidine and glycine exhibit anti‐inflammatory effects in human coronary arterial endothelial cells , 2012, Clinical and experimental immunology.

[29]  M Schwab,et al.  Genomics of ADME gene expression: mapping expression quantitative trait loci relevant for absorption, distribution, metabolism and excretion of drugs in human liver , 2011, The Pharmacogenomics Journal.

[30]  C. Gieger,et al.  Human metabolic individuality in biomedical and pharmaceutical research , 2011, Nature.

[31]  Fabian J Theis,et al.  Discovery of Sexual Dimorphisms in Metabolic and Genetic Biomarkers , 2011, PLoS genetics.

[32]  Bin Zhang,et al.  A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort. , 2011, Genome research.

[33]  Christopher D. Brown,et al.  Identification, Replication, and Functional Fine-Mapping of Expression Quantitative Trait Loci in Primary Human Liver Tissue , 2011, PLoS genetics.

[34]  Thomas W. Mühleisen,et al.  Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease , 2011, Nature Genetics.

[35]  Brian J. Bennett,et al.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.

[36]  D. Conti,et al.  Genetic contribution of the leukotriene pathway to coronary artery disease , 2011, Human Genetics.

[37]  M. Lever,et al.  The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism. , 2010, Clinical biochemistry.

[38]  Yun Li,et al.  Genome-wide association study of homocysteine levels in Filipinos provides evidence for CPS1 in women and a stronger MTHFR effect in young adults. , 2010, Human molecular genetics.

[39]  Uwe Völker,et al.  New loci associated with kidney function and chronic kidney disease , 2010, Nature Genetics.

[40]  Christian Gieger,et al.  A genome-wide perspective of genetic variation in human metabolism , 2010, Nature Genetics.

[41]  S. Hazen,et al.  Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk. , 2009, Journal of the American College of Cardiology.

[42]  R. Collins,et al.  Novel Associations of CPS1, MUT, NOX4, and DPEP1 With Plasma Homocysteine in a Healthy Population: A Genome-Wide Evaluation of 13 974 Participants in the Women’s Genome Health Study , 2009, Circulation. Cardiovascular genetics.

[43]  P. Ridker,et al.  Novel Loci, Including Those Related to Crohn Disease, Psoriasis, and Inflammation, Identified in a Genome-Wide Association Study of Fibrinogen in 17 686 Women: The Women's Genome Health Study , 2009, Circulation. Cardiovascular genetics.

[44]  K. Hiraga,et al.  Glycine cleavage system: reaction mechanism, physiological significance, and hyperglycinemia. , 2008, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[45]  John D. Storey,et al.  Mapping the Genetic Architecture of Gene Expression in Human Liver , 2008, PLoS biology.

[46]  E. Topol,et al.  Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. , 2008, JAMA.

[47]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[48]  M. Pajares,et al.  Betaine homocysteine S-methyltransferase: just a regulator of homocysteine metabolism? , 2006, Cellular and Molecular Life Sciences CMLS.

[49]  P. Ueland,et al.  Betaine: a key modulator of one-carbon metabolism and homocysteine status , 2005, Clinical chemistry and laboratory medicine.

[50]  David E. Williams,et al.  Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism. , 2005, Pharmacology & therapeutics.

[51]  D. Vaughan,et al.  Relationship Between Carbamoyl-Phosphate Synthetase Genotype and Systemic Vascular Function , 2004, Hypertension.

[52]  V. Rubio,et al.  A structure-reactivity study of the binding of acetylglutamate to carbamoyl phosphate synthetase I. , 1990, European journal of biochemistry.

[53]  V. Rubio,et al.  Physical location of the site for N-acetyl-L-glutamate, the allosteric activator of carbamoyl phosphate synthetase, in the 20-kilodalton COOH-terminal domain. , 1989, Biochemistry.

[54]  R. Schimke,et al.  Congenital hyperammonemia. Association with hyperglycinemia and decreased levels of carbamyl phosphate synthetase. , 1970, Archives of neurology.